User banner image
User avatar
  • admin

Posts

COSRX Introduces The Ceramide Skin Barrier Moisturizer: A Lightweight Yet Powerful Solution for Strengthening the Skin Barrier

NEW YORK, March 14, 2025 /PRNewswire/ — For those frustrated with heavy, greasy moisturizers that clog pores or leave the skin feeling weighed down, Korean beauty...

Emeren Announces Fourth Quarter and Full Year 2024 Financial Results

–  Delivered Strong Free Cash Flow in Q4 2024–  Achieved High-Margin Expansion Driven by IPP and DSA Businesses NORWALK, Conn., March 14, 2025 /PRNewswire/ —...

XWELL Announces Plan for Strategic Investment in Medical Spas to Advance Wellness and Beauty Offerings

$4M Private Placement Fuels Expansion, with Initial Acquisitions Planned by Year-End NEW YORK, March 13, 2025 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or...

Iterate.ai Chief Digital Officer and Co-Founder Brian Sathianathan Named 2025 Top Retail Expert by RETHINK Retail

Sathianathan is recognized for advancing AI innovation and emerging technologies across the retail industry SAN JOSE, Calif. and DENVER, March 13, 2025 (GLOBE NEWSWIRE) —...

E.L.F. BEAUTY SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against e.l.f. Beauty, Inc. – ELF

NEW ORLEANS, March 12, 2025 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 5, 2025 to file...

NKGen Biotech To Present on Potential of Troculeucel for the Treatment of Neurodegenerative Diseases at the 13th Annual Alzheimer’s & Parkinson’s Drug Development Summit

SANTA ANA, Calif., March 13, 2025 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the...

Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call on March 20

Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) — Vaxart, Inc. (NASDAQ: VXRT) today announced it will...

Adagene to Present at 11th Annual Immuno-Oncology 360⁰ Summit

SAN DIEGO and SUZHOU, China, March 13, 2025 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel...

FDA Study May Proceed Notice Received for Phase 2 Trial of TPST-1495 for the Treatment of Familial Adenomatous Polyposis (FAP)

Second clinical program entering Phase 2 with data expected 2026 BRISBANE, Calif., March 13, 2025 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage...

REPEAT/MEDIA ADVISORY: Health Coalition to announce response to court rulings on Bill 7 Charter Challenge and Orchard Villa case

TORONTO, March 13, 2025 (GLOBE NEWSWIRE) — The courts have ruled on two cases impacting thousands of elderly hospital patients and long-term care residents in...